110 related articles for article (PubMed ID: 26794219)
1. Comment on: "Effect of a topical nonsteroidal anti-inflammatory agent (0.1 % pranoprofen) on acute central serous chorioretinopathy".
Kaya A; Aksoy Y; Sevinç MK; Diner O
Graefes Arch Clin Exp Ophthalmol; 2016 Jul; 254(7):1429. PubMed ID: 26794219
[No Abstract] [Full Text] [Related]
2. Effect of a topical nonsteroidal anti-inflammatory agent (0.1 % pranoprofen) on acute central serous chorioretinopathy: author's response.
Kwon YH; An SH
Graefes Arch Clin Exp Ophthalmol; 2016 Jul; 254(7):1431-2. PubMed ID: 26794221
[No Abstract] [Full Text] [Related]
3. Effect of a topical nonsteroidal anti-inflammatory agent (0.1 % pranoprofen) on acute central serous chorioretinopathy.
An SH; Kwon YH
Graefes Arch Clin Exp Ophthalmol; 2016 Aug; 254(8):1489-1496. PubMed ID: 26553195
[TBL] [Abstract][Full Text] [Related]
4. [Effects of pre-instilled mydriatics on the intraocular concentration and anti-inflammatory action of topical 0.1% pranoprofen].
Ogawa T; Ohara K; Ohira M
Nippon Ganka Gakkai Zasshi; 1988 Sep; 92(9):1510-9. PubMed ID: 3265023
[No Abstract] [Full Text] [Related]
5. The effect of topical pranoprofen 0.1% on the clinical evaluation and conjunctival HLA-DR expression in dry eyes.
Liu X; Wang S; Kao AA; Long Q
Cornea; 2012 Nov; 31(11):1235-9. PubMed ID: 22677643
[TBL] [Abstract][Full Text] [Related]
6. Topical pranoprofen 0.1% is as effective anti-inflammatory and analgesic agent as diclofenac sodium 0.1% after strabismus surgery.
Akyol-Salman I; Leçe-Sertöz D; Baykal O
J Ocul Pharmacol Ther; 2007 Jun; 23(3):280-3. PubMed ID: 17593012
[TBL] [Abstract][Full Text] [Related]
7. Biopharmaceutical profile of pranoprofen-loaded PLGA nanoparticles containing hydrogels for ocular administration.
Abrego G; Alvarado H; Souto EB; Guevara B; Bellowa LH; Parra A; Calpena A; Garcia ML
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):261-70. PubMed ID: 25681744
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of topical pranoprofen and fluorometholone in cases with chronic allergic conjunctivitis.
Li Z; Mu G; Chen W; Gao L; Jhanji V; Wang L
Cornea; 2013 May; 32(5):579-82. PubMed ID: 23023407
[TBL] [Abstract][Full Text] [Related]
9. Effect of topical nonsteroidal anti-inflammatory drugs and nuclear hardness on maintenance of mydriasis during phacoemulsification surgery.
Liu C; Liu Y; Ye S; Liu L; Zhang W; Wu M
J Ocul Pharmacol Ther; 2014 Dec; 30(10):831-6. PubMed ID: 25230350
[TBL] [Abstract][Full Text] [Related]
10. [Clinical use of pranoprofen for the pain following tooth extraction].
Obe D; Ito Y; Koga T
Shikai Tenbo; 1985 Oct; 66(4):915-20. PubMed ID: 3879390
[No Abstract] [Full Text] [Related]
11. The Toxicity of Nonsteroidal Anti-inflammatory Eye Drops against Human Corneal Epithelial Cells in Vitro.
Lee JS; Kim YH; Park YM
J Korean Med Sci; 2015 Dec; 30(12):1856-64. PubMed ID: 26713063
[TBL] [Abstract][Full Text] [Related]
12. A new treatment approach - Eplerenone - in central serous chorioretinopathy - Case report.
Cioboata M; Alexandrescu C; Hopinca CA; Pienaru MC; Merticariu A; Schmitzer S
J Med Life; 2016; 9(1):92-94. PubMed ID: 27713772
[TBL] [Abstract][Full Text] [Related]
13. Biopharmaceutical profile of hydrogels containing pranoprofen-loaded PLGA nanoparticles for skin administration: In vitro, ex vivo and in vivo characterization.
Abrego G; Alvarado H; Souto EB; Guevara B; Bellowa LH; Garduño ML; Garcia ML; Calpena AC
Int J Pharm; 2016 Mar; 501(1-2):350-61. PubMed ID: 26844786
[TBL] [Abstract][Full Text] [Related]
14. [Analgesic effects of Niflan (pranoprofen) for postoperative pain in minor oral surgery].
Murayama S; Tashiro M; Nagamine G; Ogata H; Nakajima T
Shikai Tenbo; 1985 Jan; 65(1):221-7. PubMed ID: 3871973
[No Abstract] [Full Text] [Related]
15. Enhanced transdermal absorption and pharmacokinetic evaluation of pranoprofen-ethylene-vinyl acetate matrix containing penetration enhancer in rats.
Cho CW; Choi JS; Yang KH; Shin SC
Arch Pharm Res; 2009 May; 32(5):747-53. PubMed ID: 19471890
[TBL] [Abstract][Full Text] [Related]
16. [Pranoprofen-induced lung injury manifesting as acute eosinophilic pneumonia].
Fujimori K; Shimatsu Y; Suzuki E; Gejyo F; Arakawa M
Nihon Kokyuki Gakkai Zasshi; 1999 May; 37(5):401-5. PubMed ID: 10410543
[TBL] [Abstract][Full Text] [Related]
17. The influence of fever on the pharmacokinetics of pranoprofen in elderly subjects.
Fujimura A; Kajiyama H; Ebihara A
J Clin Pharmacol; 1989 Jun; 29(6):500-3. PubMed ID: 2787808
[TBL] [Abstract][Full Text] [Related]
18. [Effect of topical pranoprofen on the lipoxygenase metabolism of the arachidonic and in endotoxin-induced uveitis].
Torrón C; Ferrer E; Ruiz-Moreno O; Cuevas R; Pérez S; Alabart JL; Honrubia FM
Arch Soc Esp Oftalmol; 2000 Jun; 75(6):377-82. PubMed ID: 11151181
[TBL] [Abstract][Full Text] [Related]
19. [Effects of pre-instilled mydriatics on the intraocular concentration and anti-inflammatory action of topical 0.1% pranoprofen (3)--study on permeability factor].
Ogawa T; Ohara K; Shimizu H
Nippon Ganka Gakkai Zasshi; 1992 Nov; 96(11):1379-86. PubMed ID: 1476068
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficiency of Helicobacter pylori eradication in the treatment of patients with acute central serous chorioretinopathy.
Zavoloka O; Bezditko P; Lahorzhevska I; Zubkova D; Ilyina Y
Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1737-42. PubMed ID: 26979068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
